Pharmaceutical - edoxaban

Filter

Current filters:

edoxaban

Popular Filters

Perosphere and Daiichi Sankyo collaborate on Ph III study of PER977 with edoxaban

Perosphere and Daiichi Sankyo collaborate on Ph III study of PER977 with edoxaban

07-10-2014

USA-based Perosphere has entered into a third clinical trial collaboration agreement with Japanese pharma…

Cardio-vascularDaiichi SankyoedoxabanHematologyJapanPER977PerospherePharmaceuticalPortola PharmaceuticalsResearch

Portola in second deal with Daiichi Sankyo for Factor Xa inhibitor antidote

Portola in second deal with Daiichi Sankyo for Factor Xa inhibitor antidote

10-07-2014

USA-based Portola Pharmaceuticals has entered into a second clinical collaboration agreement with Japanese…

andexanet alfaCardio-vascularDaiichi SankyoedoxabanJapanLicensingPharmaceuticalPortola PharmaceuticalsResearchSavaysaUSA

Daiichi Sankyo submits edoxaban application to the EMA for stroke prevention

Daiichi Sankyo submits edoxaban application to the EMA for stroke prevention

08-01-2014

Japanese drug major Daiichi Sankyo (TYO: 4568) has submitted a Marketing Authorization Application to…

Asia-PacificCardio-vascularDaiichi SankyoedoxabanPharmaceuticalRegulation

Daiichi Sankyo's edoxaban shows comparable efficacy to warfarin in Phase III trial

Daiichi Sankyo's edoxaban shows comparable efficacy to warfarin in Phase III trial

20-11-2013

Japanese drug major Daiichi Sankyo (TYO: 4568) says that its blood thinner edoxaban met the primary efficacy…

Asia-PacificCardio-vascularDaiichi SankyoedoxabanPharmaceuticalResearchWarfarin Sodium

Positive Ph III results for Daiichi Sankyo's edoxaban in VTE

02-09-2013

Japanese drug major Daiichi Sankyo (TYO: 4568) has released encouraging results from the global Phase…

Cardio-vascularDaiichi SankyoedoxabanLixianaPharmaceuticalResearch

Daiichi Sankyo to support Phase I clinical study of anticoagulant activity reverser for edoxaban

25-04-2013

USA-based Perosphere and Japanese drug major Daiichi Sankyo(TYO: 4568) have entered into a clinical trial…

Cardio-vascularDaiichi SankyoedoxabanPER977PharmaceuticalResearch

Back to top